EUVIMED · CrossrefZeitschrift
JACC: Asia
ISSN 2772-3747 · Elsevier BV
Neueste Artikel
Lead-Attributable Cardiovascular Disease Burden in North Africa and the Middle East
Multimodality Imaging–Based Phenotyping and Prognostic Implications of Right Ventricular Involvement in Apical Hypertrophic Cardiomyopathy
Angiography-Derived Index of Microcirculatory Resistance Predicts Microvascular Obstruction and Infarct Size in Patients With STEMI
Real-World Evaluation of a Nationally Mandated Risk Stratification Tool for Destination Therapy LVAD in Japan
Plasma Proteins Associated With Incident Acute Myocardial Infarction in Asians With Type 2 Diabetes
Epidemiological Analysis and 2040 Projections of Atrial Fibrillation and Flutter in Asia
Adverse Events and ABC Pathway Adherence Across AF Clinical Phenotypes
A Mandated Risk Score Meets Real-World Destination Therapy
Three-Dimensional Strain Parameters for Quantifying Replacement Fibrosis in Hypertrophic Cardiomyopathy
Stroke Burden, Trends, and Inequalities in the Western Pacific Region, 1990-2021
Atrial Fibrillation in Asia
Impact of Renal Dysfunction on FFR- or IVUS-Guided PCI for Intermediate Coronary Stenosis
Prevalence of Transthyretin Amyloidosis Among Older Taiwanese Patients With Heart Failure With Preserved Ejection Fraction
Coronary Microvascular Dysfunction in Myocardial Infarction
Osteosarcopenia as a Risk Factor for Atrial Fibrillation
Monotherapy Versus Combination Therapy Beyond 12 Months After Coronary Intervention in Older Atrial Fibrillation Patients
Stroke Burden in the Western Pacific
Novel MYH7 Variants in Indian Patients With Hypertrophic Cardiomyopathy
Management of Coronary Calcified Nodules: A Position Statement
Prognostic Implication of CYP2C19 Genotype During Chronic Clopidogrel Monotherapy After Percutaneous Coronary Intervention
Beyond Bone and Muscle
Clinical Phenotypes and Integrated Care in Atrial Fibrillation
Snare-Assisted Traction Technique for Renal Artery Reconstruction in Endovascular Repair of Complex Thoracoabdominal Aortic Aneurysms
Beyond Conventional Risk
The Limits of Pharmacogenetics and Clinical Trials
The FLAVOUR of Choice Between FFR and IVUS
Three-Dimensional Strain for Assessing Myocardial Fibrosis in Hypertrophic Cardiomyopathy
Right Ventricular Involvement in Apical Hypertrophic Cardiomyopathy
When Cardiovascular Progress Meets Population Aging
Antithrombotic Treatment After PCI in Older Patients With Atrial Fibrillation
EUVIMED